These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8616985)

  • 1. Micronized progesterone: vaginal and oral uses.
    Simon JA
    Clin Obstet Gynecol; 1995 Dec; 38(4):902-14. PubMed ID: 8616985
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of oral administration of dydrogestrone versus vaginal administration of natural micronized progesterone on the secretory transformation of endometrium and luteal endocrine profile in patients with premature ovarian failure: a proof of concept.
    Fatemi HM; Bourgain C; Donoso P; Blockeel C; Papanikolaou EG; Popovic-Todorovic B; Devroey P
    Hum Reprod; 2007 May; 22(5):1260-3. PubMed ID: 17227809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral micronized progesterone. Bioavailability pharmacokinetics, pharmacological and therapeutic implications--a review.
    Sitruk-Ware R; Bricaire C; De Lignieres B; Yaneva H; Mauvais-Jarvis P
    Contraception; 1987 Oct; 36(4):373-402. PubMed ID: 3327648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of oral micronized progesterone when applied via vaginal route.
    Choavaratana R; Manoch D
    J Med Assoc Thai; 2004 May; 87(5):455-8. PubMed ID: 15222511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Micronized progesterone: a new option for women's health care.
    Wetzel W
    Nurse Pract; 1999 May; 24(5):62-6, 71, 75-6. PubMed ID: 10349670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uses of progesterone in clinical practice.
    Warren MP; Shantha S
    Int J Fertil Womens Med; 1999; 44(2):96-103. PubMed ID: 10338267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Micronized progesterone: clinical indications and comparison with current treatments.
    Fitzpatrick LA; Good A
    Fertil Steril; 1999 Sep; 72(3):389-97. PubMed ID: 10519605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Modern therapy with micronized of progesterone--utrogestan for menstrual disturbances].
    Sirakov M
    Akush Ginekol (Sofiia); 2001; 40 Suppl 5():22-4. PubMed ID: 11785350
    [No Abstract]   [Full Text] [Related]  

  • 9. Progesterone for premenstrual tension.
    Norris RV
    J Reprod Med; 1983 Aug; 28(8):509-16. PubMed ID: 6355465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
    Cianci A; De Leo V
    Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of progesterone and its 5 alpha and 5 beta metabolites on symptoms of premenstrual syndrome according to route of administration.
    Vanselow W; Dennerstein L; Greenwood KM; de Lignieres B
    J Psychosom Obstet Gynaecol; 1996 Mar; 17(1):29-38. PubMed ID: 8860884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effects of micronized natural progesterone on the liver during the third trimester of pregnancy].
    Benifla JL; Dumont M; Levardon M; Foucher E; Cadiot G; Crenn-Hebert C; Heid M; Lelaidier C; Rosenbaum A; Bernuau J; Erlinger S; Frydman R; Madelenat P
    Contracept Fertil Sex; 1997 Feb; 25(2):165-9. PubMed ID: 9116778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progesterone for premenstrual syndrome.
    Med Lett Drugs Ther; 1984 Nov; 26(674):101-2. PubMed ID: 6387416
    [No Abstract]   [Full Text] [Related]  

  • 14. [Nonoral administration of progesterone: results and prospects of the transvaginal route].
    De Ziegler D; Seidler L; Schrer E; Bouchard P
    Rev Med Suisse Romande; 1994 Sep; 114(9):811-7. PubMed ID: 7939114
    [No Abstract]   [Full Text] [Related]  

  • 15. Endometrial response to a cyclic regimen of percutaneous 17beta-estradiol and low-dose vaginal micronized progesterone in women with mild-to-moderate hypertension.
    Vilodre LC; Osório Wender MC; Sisson de Castro JA; dos Reis FM; Ruschel S; Magalhães JA; Spritzer PM
    Gynecol Endocrinol; 2003 Aug; 17(4):323-8. PubMed ID: 14503977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with withdrawal bleeding after administration of oral micronized progesterone in women with secondary amenorrhea.
    Shangold MM; Tomai TP; Cook JD; Jacobs SL; Zinaman MJ; Chin SY; Simon JA
    Fertil Steril; 1991 Dec; 56(6):1040-7. PubMed ID: 1743319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A meta-analysis of the route of administration of luteal phase support in assisted reproductive technology: vaginal versus intramuscular progesterone.
    Zarutskie PW; Phillips JA
    Fertil Steril; 2009 Jul; 92(1):163-9. PubMed ID: 19362303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral micronized progesterone.
    de Lignières B
    Clin Ther; 1999 Jan; 21(1):41-60; discussion 1-2. PubMed ID: 10090424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progesterone organogel for premenstrual dysphoric disorder.
    Capps S
    J Am Acad Child Adolesc Psychiatry; 2001 Mar; 40(3):261. PubMed ID: 11288763
    [No Abstract]   [Full Text] [Related]  

  • 20. [Luteal phase support after vaginal progesterone: comparative study with micronized oral progesterone].
    Pouly JL; Bassil S; Frydman R; Hédon B; Nicollet B; Prada Y; Antoine JM; Zambrano R; Donnez J
    Contracept Fertil Sex; 1997; 25(7-8):596-601. PubMed ID: 9410372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.